Endogenous plasmid engineering of probiotic Escherichia coli Nissle 1917 for the antibiotic-free indigo production
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Transgenic Plants and Applications · Microbial Metabolism and Applications · Bioeconomy and Sustainability Development
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Modern industrial and pharmacological applications of indigo dye and its derivatives--a review
2. Early Pre-hispanic use of indigo blue in Peru10.1126/sciadv.1501623 ↗
3. Research progress of food colouring agent
4. Production of indigo by recombinant bacteria10.1186/s40643-023-00626-7 ↗
5. An overview of microbial indigo-forming enzymes10.1007/s00253-019-10292-5 ↗
6. Paul · 2021
7. Quantification of aniline and N-metahylaniline in indigo10.1038/s41598-021-00634-7 ↗
8. Overview of indigo biosynthesis by flavin-containing monooxygenases: history, induastrialization challenges, and strategies10.1016/j.biotechadv.2024.108374 ↗
9. Auto-inducible synthetic pathway in E. coli enhanced sustainable indigo production from glucose10.1016/j.ymben.2024.07.002 ↗
10. Metabolic engineering of Escherichia coli BL21(DE3) for efficient production of indigo using Methylophaga aminisulfidivorans flavin-containing monooxygenase
11. Research progress, challenges, and perspectives in microbial pigment production for industrial applications - a review
12. Enhancement of indigo production by a metabolically engineered Escherichia coli MG1655 using membrane engineering and two-stage cultivation10.1021/acs.jafc.5c01400 ↗
13. Identification of a novel oxygenase capable of regiospecific hydroxylation of D-limonene into (+)-trans-carveol
14. Cloning and expression in Escherichia coli of the toluene dioxygenase gene from Pseudomonas putida NCIB1176710.1111/j.1574-6968.1989.tb03352.x ↗
15. Enhancing indigo production by over-expression of the styrene monooxygenase in Pseudomonas putida10.1007/s00284-016-1055-3 ↗
16. A combinational optimization method for efficient production of indigo by the recombinant Escherichia coli with expression of monooxygenase and malate dehydrogenase10.3390/foods12030502 ↗
17. Indigoid dyes by group E monooxygenases: mechanism and biocatalysis10.1515/hsz-2019-0109 ↗
18. The extreme structural plasticity in the CYP153 subfamily of P450s directs development of designer hydroxylases10.1021/acs.biochem.8b01052 ↗
19. In vitro characterization of CYP102G4 from Streptomyces cattleya: a self-sufficient P450 naturally producing indigo10.1016/j.bbapap.2017.08.002 ↗
20. Biosynthesis of indigo in Escherichia coli expressing self-sufficient CYP102A from Streptomyces cattleya10.1016/j.dyepig.2017.01.029 ↗
21. Production of indigo through the use of a dualfunction substrate and a bifunctional fusion enzyme
22. Structure-guided engineering of a flavin-containing monooxygenase for the efficient production of indirubin10.1186/s40643-022-00559-7 ↗
23. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients10.2165/11632710-000000000-00000 ↗
24. Plasmid vectors for in vivo selection-free use with the probiotic E. coli Nissle 191710.1021/acssynbio.0c00466 ↗
25. Improved cryptic plasmids in probiotic Escherichia coli Nissle 1917 for antibiotic-free pathway engineering10.1007/s00253-023-12662-6 ↗
26. An Escherichia coli Nissle 1917-based live therapeutics platform with integrated phage resistance and programmable temperature sensitivity
27. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia10.1038/s41467-024-44776-4 ↗
28. Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism10.1038/s41467-022-31334-z ↗
29. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria10.1038/nbt.4222 ↗
30. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study10.1038/s42255-021-00430-7 ↗
31. Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial10.1038/s42255-023-00897-6 ↗
32. A novel flavin-containing monooxygenase from Methylophaga sp. strain SK1 and its indigo synthesis in Escherichia coli10.1016/S0006-291X(03)01087-8 ↗
33. Internal dynamics of the tryptophan repressor (TrpR) and two functionally distinct TrpR variants, L75F-TrpR and A77V-TrpR, in their L-Trp bound forms10.1021/bi200389k ↗
34. Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system10.1128/AEM.04023-14 ↗
35. Improved production of tryptophan in genetically engineered Escherichia coli with TktA and PpsA overexpression
36. Elucidating cysteineassisted synthesis of indirubin by a flavin-containing monooxygenase10.1021/acscatal.9b02613 ↗
37. Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties10.1093/femsle/fnw212 ↗
38. Extending shikimate pathway for the production of muconic acid and its precursor salicylic acid in Escherichia coli10.1016/j.ymben.2014.02.009 ↗
39. Multidimensional engineering of Escherichia coli for efficient synthesis of L-tryptophan10.1016/j.biortech.2023.129475 ↗
40. Metabolic design of a platform Escherichia coli strain producing various chorismate derivatives10.1016/j.ymben.2015.11.007 ↗
41. Central metabolic pathway modification to improve L-tryptophan production in Escherichia coli10.1080/21655979.2019.1592417 ↗
42. YddG from Escherichia coli promotes export of aroamatic amino acids10.1111/j.1574-6968.2007.00894.x ↗
43. Production of indigo by recombinant Escherichia coli with expression of monooxygenase, tryptophanase, and molecular chaperone10.3390/foods11142117 ↗
44. Development of L-tryptophan production strains by defined genetic modification in Escherichia coli10.1007/s10295-011-0978-8 ↗
45. Employing a biochemical protecting group for a sustainable indigo dyeing strategy10.1038/nchembio.2552 ↗
46. Enhanced production of bio-indigo in engineered Escherichia coli, reinforced by cyclopropane-fatty acid-acyl-phospholipid synthase from psychrophilic Pseudomonas sp. B14-610.1016/j.jbiotec.2023.02.008 ↗
47. Indigo and tyrian purple-from ancient natural dyes to modern organic semiconductors10.1002/ijch.201100130 ↗
48. Efficient bioproduction of indigo and indirubin by optimizing a novel terpenoid cyclase XiaI in Escherichia coli10.1021/acsomega.1c02679 ↗
49. Reconstruction of the personal information from human genome reads in gut metagenome sequencing data10.1038/s41564-023-01381-3 ↗
50. Enhancing indican production in Escherichia coli through a multi-faceted experimental strategy